Furthermore, ARHL was associated with higher levels of CSF total tau and p-Tau 181, and neuropathological and in vivo studies indicated that tau pathology could induce cognitive impairment across the AD spectrum via synaptic dysfunction and neuronal loss [54,55]. This evidence concerns the gene MAPT and Alzheimer disease.